Got your BAQ resources

Watch the following video to learn how to administer BAQSIMI. Share it with your family, friends or coworkers so they can administer BAQSIMI in case of emergency.

BAQSIMI Expiration Reminder Tool

Use our Expiration Reminder Tool to get a reminder 3 and 1 month(s) prior, and on the day your BAQSIMI expires, by e-mail and/or text. Call your healthcare professional or visit your pharmacist at that time to refill your prescription.

todo

Step 1: Name your BAQSIMI

Name your device
If you have more than one, name it after the place/location you store it, i.e. home, school, bag

Step 2: Select the expiry date on the tube of your BAQSIMI

Select the expiry date
(YYYY-MM-DD) Each BAQSIMI device can have a different expiry date, even if you received the devices on the same day.

Step 3: Enter contact information and preference

You can receive expiration reminders by Text, Email, or both

I would like to receive occasional updates about BAQSIMI, as well as other BAQSIMI related information, services, and events. I acknowledge that I can withdraw my consent at any time.

By clicking Submit, I acknowledge and agree to the Terms of Use and Privacy Statement for this site.

Clinical use:
BAQSIMI has not been studied in pediatric patients less than 4 years old.

Limited clinical trial experience has not identified difference in responses between elderly (≥65 years of age) and younger patients.

Contraindications:

Hypersensitivity to glucagon or to any ingredient in the formulation or container
Pheochromocytoma
Insulinoma

Most serious warnings and precautions:
Lack of response: BAQSIMI should be given only in patients where impaired consciousness precludes oral carbohydrates. After intranasal administration of BAQSIMI, the patient will normally respond within 15 minutes. If the patient does not respond within 15 minutes, intravenous glucose must be administered as soon as possible.

States of starvation, adrenal insufficiency or chronic hypoglycemia: Because glucagon is of little or no help in these cases, intravenous glucose should be used for the treatment of hypoglycemia in these conditions.

Other relevant warnings and precautions:

Cardiovascular effects
Driving and operating machinery
Pheochromocytoma
Insulinoma
Sensitivity and resistance to glucagon
Pregnant women
Breast-feeding
Pediatrics (<4 years of age)
Geriatrics (>65 years of age)
Use in patients with Type 2 diabetes taking sulfonylureas
Use with alcohol
Monitoring and laboratory tests

For more information:
Consult the product monograph at http://pi.lilly.com/ca/baqsimi-ca-pm.pdf for additional important information relating to warnings and precautions, adverse reactions, drug interactions and dosing information which have not been discussed in this piece. The product monograph is also available by calling 1-888-545-5972.